Talk:RTI-51

From Wikipedia, the free encyclopedia
Jump to: navigation, search
WikiProject Pharmacology  
WikiProject icon This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
 ???  This article has not yet received a rating on the project's quality scale.
 ???  This article has not yet received a rating on the project's importance scale.
 
WikiProject Chemicals (Rated Start-class, Low-importance)
WikiProject icon This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.
Start-Class article Start  This article has been rated as Start-Class on the project's quality scale.
 Low  This article has been rated as Low-importance on the project's importance scale.
 

Possible Original Research I tagged this because the tone of the article sounds like original research. Particularly the following:


For example, it is not documented to have been experimented with on man.

Another choice of ester should be tried, such as cyclopropyl, for example.

The rationale is that less "non-specific" binding is believed to reduce toxicity.

RTI-51 can be expected to have properties lying somewhere in between RTI-31 and RTI-55.

Thus, if accurate data is available for RTI-31 and RTI-55, then the data of RTI-51 can be deducted.


Is this from some of the references? Can it be rewritten some way to make it clear that the references say this? ChemGardener (talk) 02:26, 9 August 2009 (UTC)

Changed wording and added reference. Meodipt (talk) 05:59, 17 August 2009 (UTC)